Positive Data Backs Inivata's T790 Test For Use in Non-Biopsy Lung Cancer Patients
Executive Summary
Positive data from a recently published study has backed the use of Inivata's liquid biopsy platform for detecting T790 mutations in lung cancer patients unable to undergo tissue biopsies.